We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRI icon
851
Monarch Casino & Resort
MCRI
$2.2B
$341K ﹤0.01%
+6,071
New +$372K
FRC
852
DELISTED
First Republic Bank
FRC
$339K ﹤0.01%
2,599
PRMW
853
DELISTED
Primo Water Corporation
PRMW
$336K ﹤0.01%
26,791
ONB icon
854
Old National Bancorp
ONB
$10.2B
$334K ﹤0.01%
20,296
-45,999
-69% -$769K
TSE
855
DELISTED
Trinseo
TSE
$330K ﹤0.01%
18,021
+2,285
+15% +$71.5K
XPEL icon
856
XPEL
XPEL
$1.22B
$329K ﹤0.01%
5,100
+400
+9% +$26K
TU icon
857
Telus
TU
$17.4B
$324K ﹤0.01%
+16,311
New +$364K
CRVL icon
858
CorVel
CRVL
$3.18B
$319K ﹤0.01%
+6,918
New +$359K
SHEN icon
859
Shenandoah Telecom
SHEN
$703M
$319K ﹤0.01%
18,716
-16,387
-47% -$350K
MEI icon
860
Methode Electronics
MEI
$458M
$313K ﹤0.01%
8,413
-12,447
-60% -$487K
ABM icon
861
ABM Industries
ABM
$2.89B
$312K ﹤0.01%
8,163
-19,072
-70% -$835K
PYPL icon
862
PayPal
PYPL
$50.3B
$298K ﹤0.01%
3,466
UMPQ
863
DELISTED
Umpqua Holdings Corp
UMPQ
$297K ﹤0.01%
17,400
CMRC
864
Commerce.com Inc Series 1
CMRC
$272M
$295K ﹤0.01%
19,900
-5,000
-20% -$85.8K
SXC icon
865
SunCoke Energy
SXC
$794M
$295K ﹤0.01%
50,752
-83,812
-62% -$563K
AP icon
866
Ampco-Pittsburgh
AP
$163M
$291K ﹤0.01%
79,002
RJF icon
867
Raymond James Financial
RJF
$33.5B
$287K ﹤0.01%
2,900
RYAM icon
868
Rayonier Advanced Materials
RYAM
$562M
$279K ﹤0.01%
88,476
-95,306
-52% -$381K
AEYE icon
869
AudioEye
AEYE
$71.5M
$275K ﹤0.01%
50,000
EIC
870
Eagle Point Income Co
EIC
$228M
$274K ﹤0.01%
19,341
GBL
871
DELISTED
GAMCO Investors, Inc.
GBL
$273K ﹤0.01%
+16,000
New +$323K
SEMR
872
DELISTED
Semrush
SEMR
$267K ﹤0.01%
23,800
-10,700
-31% -$132K
UVV icon
873
Universal Corp
UVV
$1.37B
$267K ﹤0.01%
5,795
-5,456
-48% -$286K
ENV
874
DELISTED
ENVESTNET, INC.
ENV
$266K ﹤0.01%
6,000
LMAT icon
875
LeMaitre Vascular
LMAT
$2.37B
$260K ﹤0.01%
5,134
-3,737
-42% -$187K

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.